- Home
- AMPH vs DGNX Comparison
AMPH vs DGNX Comparison
Compare AMPH & DGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- DGNX
- Stock Information
- Founded
- AMPH 1996
- DGNX 2018
- Country
- AMPH United States
- DGNX United Kingdom
- Employees
- AMPH N/A
- DGNX N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- DGNX
- Sector
- AMPH Health Care
- DGNX
- Exchange
- AMPH Nasdaq
- DGNX NYSE
- Market Cap
- AMPH 1.1B
- DGNX 1.2B
- IPO Year
- AMPH 2014
- DGNX 2025
- Fundamental
- Price
- AMPH $23.89
- DGNX $47.00
- Analyst Decision
- AMPH Hold
- DGNX
- Analyst Count
- AMPH 5
- DGNX 0
- Target Price
- AMPH $38.00
- DGNX N/A
- AVG Volume (30 Days)
- AMPH 507.4K
- DGNX 48.3K
- Earning Date
- AMPH 08-06-2025
- DGNX 01-01-0001
- Dividend Yield
- AMPH N/A
- DGNX N/A
- EPS Growth
- AMPH N/A
- DGNX N/A
- EPS
- AMPH 2.77
- DGNX N/A
- Revenue
- AMPH $730,659,000.00
- DGNX $1,177,066.00
- Revenue This Year
- AMPH $0.67
- DGNX N/A
- Revenue Next Year
- AMPH $5.18
- DGNX N/A
- P/E Ratio
- AMPH $8.26
- DGNX N/A
- Revenue Growth
- AMPH 8.05
- DGNX N/A
- 52 Week Low
- AMPH $22.64
- DGNX $3.60
- 52 Week High
- AMPH $53.96
- DGNX $155.00
- Technical
- Relative Strength Index (RSI)
- AMPH 34.01
- DGNX N/A
- Support Level
- AMPH $22.81
- DGNX N/A
- Resistance Level
- AMPH $25.04
- DGNX N/A
- Average True Range (ATR)
- AMPH 0.67
- DGNX 0.00
- MACD
- AMPH -0.33
- DGNX 0.00
- Stochastic Oscillator
- AMPH 6.38
- DGNX 0.00
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About DGNX DIGINEX LIMITED
Diginex Ltd is an investment holding company. It engaged in providing Environmental, Social, and Governance (ESG) reporting solution services, advisory services, and developing customization solutions.